D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
eHealth
EHTH
$43.8M
| $2.7M | ﹤0.01% |
217,760
+200,679
| +1,175% | +$3.46M |
|
2852
CALL
Thomson Reuters
TRI
$43.1B
| $2.7M | ﹤0.01% |
23,537
| – | – |
|
|
BRACU
2853
DELISTED
Broad Capital Acquisition Corp Unit
BRACU
| $2.69M | ﹤0.01% |
+268,605
| New | +$2.7M |
|
|
LAC
2854
CALL
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $2.69M | ﹤0.01% |
70,000
-80,000
| -53% | -$2.28M |
|
|
TRUE
2855
DELISTED
TrueCar
TRUE
| $2.69M | ﹤0.01% |
680,133
-371,925
| -35% | -$1.31M |
|
2856
PUT
KE Holdings
BEKE
$18.8B
| $2.69M | ﹤0.01% |
217,100
-50,000
| -19% | -$891K |
|
|
CFFSU
2857
DELISTED
CF Acquisition Corp. VII Unit
CFFSU
| $2.68M | ﹤0.01% |
266,667
-133,333
| -33% | -$1.33M |
|
|
LKFT
2858
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
| $2.68M | ﹤0.01% |
43,215
-94,125
| -69% | -$5.76M |
|
2859
MiMedx Group
MDXG
$636M
| $2.68M | ﹤0.01% |
568,864
+113,044
| +25% | +$553K |
|
2860
SeaStar Medical
ICU
$12.7M
| $2.67M | ﹤0.01% |
1,055
+160
| +18% | +$403K |
|
2861
Comscore
SCOR
$112M
| $2.67M | ﹤0.01% |
45,855
-3,299
| -7% | -$189K |
|
|
EPZM
2862
DELISTED
Epizyme, Inc
EPZM
| $2.67M | ﹤0.01% |
2,320,698
+2,061,176
| +794% | +$3.36M |
|
2863
Collegium Pharmaceutical
COLL
$1.17B
| $2.67M | ﹤0.01% |
130,964
+11,659
| +10% | +$220K |
|
|
MODV
2864
DELISTED
ModivCare
MODV
| $2.67M | ﹤0.01% |
23,103
+21,750
| +1,608% | +$2.51M |
|
2865
CALL
Repligen
RGEN
$7.03B
| $2.65M | ﹤0.01% |
14,100
-9,500
| -40% | -$1.8M |
|
|
SGEN
2866
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.65M | ﹤0.01% |
18,413
-42,249
| -70% | -$5.72M |
|
2867
CALL
Marqeta
MQ
$1.86B
| $2.65M | ﹤0.01% |
+60,000
| New | +$2.79M |
|
|
CELL
2868
DELISTED
PhenomeX Inc. Common Stock
CELL
| $2.65M | ﹤0.01% |
+372,309
| New | +$3.08M |
|
|
SQSP
2869
DELISTED
Squarespace, Inc.
SQSP
| $2.64M | ﹤0.01% |
103,161
+69,459
| +206% | +$1.98M |
|
2870
Tronox
TROX
$999M
| $2.64M | ﹤0.01% |
133,346
+59,853
| +81% | +$1.3M |
|
2871
CALL
Labcorp
LH
$25.9B
| $2.64M | ﹤0.01% |
+11,640
| New | +$2.74M |
|
2872
Chubb
CB
$135B
| $2.64M | ﹤0.01% |
12,323
+10,082
| +450% | +$2.05M |
|
|
NGMS
2873
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $2.63M | ﹤0.01% |
170,685
+82,165
| +93% | +$1.72M |
|
|
MBT
2874
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $2.63M | ﹤0.01% |
772,207
+667,104
| +635% | +$4.98M |
|
2875
nLIGHT
LASR
$3.71B
| $2.63M | ﹤0.01% |
151,471
+104,652
| +224% | +$1.97M |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.